← FDA Drug Approvals (Drugs@FDA)

POTASSIUM CITRATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIBROW HLTHCARE · Approved 2021-02-19

Drug application

FDA Application #

ANDA214426

Application type

Abbreviated New Drug Application (Generic)

Brand name

POTASSIUM CITRATE

Generic name

Potassium Citrate

Active ingredients

POTASSIUM CITRATE

Dosage form

TABLET, EXTENDED RELEASE

Route

ORAL

Marketing status

Prescription

Sponsor

HIBROW HLTHCARE

First approval

2021-02-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown